The stock market has been strong lately, leaving some investors to wonder if it has much life left in it. Goldman Sachs' chief U.S. equity strategist picked the stocks with huge upside potential that he expects to outperform the market.
The stock market has been on a tear lately (with a few minor bumps in the road). Some analysts believe that the market may be overvalued now and too expensive. However, Goldman Sachs’ chief U.S. equity strategist says there are still stocks he expects to outperform the market.
Business Insider has the full list of 40 stocks David Kostin says have the most upside potential and while the list is dominated by oil and gas firms, Goodyear, Amazon and Qualcomm make appearances. Still, half of the list is comprised of energy, mining and refining companies.
The 40 stocks on the list offer 23% to 57% upside relative to their recent prices, but here are the four health-related stocks to make it on the list.
Recent price: $98
Alexion Pharmaceuticals is the original developer and distributor of Soliris, a drug used in treating the rare disorders Hemolytic-uremic syndrome and Paroxysmal nocturnal hemoglobinuria (PNH).
Recent price: $66.65
Eastman is a global specialty chemical company that produces a broad range of advanced materials, additives and functional products, specialty chemicals, and fibers that are found in products people use every day.
Sector: Life sciences
Recent price: $30.65
Technology, services and solutions for applications such as environmental monitoring, food safety, clinical diagnostics and biomedical research.
2. Edwards Lifesciences
Recent price: $63.79
Edwards Lifesciences designs, manufactures and markets tissue heart valves and related repair products.
1. Intuitive Surgical
Sector: Health technology
Recent price: $492.29
Intuitive Surgical designs and builds the da Vinci Surgical System for robotically assisted minimally invasive surgery.